PHARMASPIRE - Volume 15, Issue 01,2023 , Jan-March

Pages: 1-7
Print Article   Download XML  Download PDF

A short review on COVID-19 and its diagnosis method

Author: Kapil Arora, Nitin Sharma

Category: Pharmaceutics

Abstract:

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus has spread to almost every country in the world, which causes fever, headache, dry cough, muscle, and chest pain. The disease potentially affects the heart, renal, and liver processes along with respiratory failure. SARS-CoV-2 viruses cause major problems to global health services. During the pandemic, diagnosis of SARS-CoV-2 infection was often confused with seasonal Influenza viral infection. However, a latent number of methods have been developed for a specific diagnostic method of SARS-CoV-2 infection. This review article compiled the different developed diagnostic methods for easy, rapid, and cost-effective identification of diseases. This article may serve as a ready reference to the researchers working in the field of SARS-CoV-2 infection.

Keywords: COVID-19, Diagnostic method, Reverse transcription polymerase chain reaction, Severe acute respiratory syndrome-coronavirus-2, Serology test, Virus detection

DOI: 10.56933/Pharmaspire.2023.15101

DOI URL: https://doi.org/10.56933/Pharmaspire.2023.15101

References:

1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3.
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74.
3. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020;87:281-6.
4. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71-6.
5. Siddell SG. The regulation of coronavirus gene expression. In: The Regulation of Gene Expression in Animal Viruses. Boston, MA: Springer; 1993. p. 163-9.
6. Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020;176:104742.
7. McLean MJ, Renaud JF, Niu MC, Sperelakis N. Membrane differentiation of cardiac myoblasts induced in vitro by an RNA-enriched fraction from adult heart. Exp Cell Res 1977;110:1-14.
8. Fung TS, Liu DX. Post-translational modifications of coronavirus proteins: Roles and function. Future Virol 2018;13:405-30.
9. Arndt AL, Larson BJ, Hogue BG. A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J Virol 2010;84:11418-28.
10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207.
12. CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343-6.
13. WHO Expert Committee on Leprosy, World Health Organization. WHO Expert Committee on Leprosy: Seventh Report. Geneva: World Health Organization; 1998. Available from: https://apps.who.int/iris/ bitstream/handle/10665/42060/WHO_TRS_874. pdf?sequence=1&isAllowed=y [Last accessed on 2022 Sep 12].
14. FDA; 2020. Available from: https://www.fda.gov/ medical-devices/emergency-situations-medical-devices/ emergency-use-authorizations#covid19ivd [Last accessed on 2022 Sep 14].
15. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: Pitfalls and potential. Biotechniques 1999;26:112-25.
16. Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M, Uchida K, et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods 2002;100:107-14.
17. CDC; 2020a. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinicalspecimens. html [Last accessed on 2022 Sep 29].
18. Hanson KE, Caliendo AM, Arias CA, Englund JA, Lee MJ, Loeb M, et al. Infectious diseases society of America guidelines on the diagnosis of COVID-19. Clin Infect Dis 2020;72:ciaa760.

19. Viracor Eurofins. Viracor Eurofins Launches Coronavirus (COVID-19) SARS-CoV-2 RT-PCR Test with Same Day Results (12-18 Hours) Clinical. United States: Eurofins- Viracor; 2020.
20. BGI. Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2; 2020. Available from: https://bgi.com [Last accessed on 2022 Sep 30].
21. Bosch Global. Vivalytic COVID-19 Rapid Test. Germany: Bosch Global; 2020.
22. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000;28:E63.
23. Available from: https://www.ingentaconnect.com/ content/cvma/cjvr/2011/00000075/00000002/art00007 [Last accessed on 2022 Sep 30].
24. Parida M, Posadas G, Inoue S, Hasebe F, Morita K. Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus. J Clin Microbiol 2004;42:257-63.
25. Ginterová A, Janotková O. A simple method of isolation and purification of cultures of wood-rotting fungi. Folia Microbiol (Praha) 1975;20:519-20.
26. Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 2017;356:438-42.
27. Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OA, Zhang E. SHERLOCK: Nucleic acid detection with CRISPR nucleases. Nat Protoc 2019;14:2986-3012.
28. Parks JM, Smith JC. How to discover antiviral drugs quickly. N Engl J Med 2020;382:2261-4.
29. Cong Y, Ulasli M, Schepers H, Mauthe M, V’Kovski P, Kriegenburg F, et al. Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J Virol 2020;94:e01925-19.
30. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 2020;52:971-7.e3.
31. Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol 2020;41:355-9.
32. Vashist SK. In vitro diagnostic assays for COVID-19: Recent advances and emerging trends. Diagnostics (Basel) 2020;10:202.
33. Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019- nCoV): Current status, challenges, and countermeasures. Rev Med Virol 2020;30:e2106.
34. Available from: https://unilabs.com/covid-testing/our-tests/ antigen [Last accessed on 2022 Oct 05].
35. World Health Organization. Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected: Interim Guidance. Geneva: World Health Organization. Available from: https://apps.who.int/iris/bitstream/ handle/10665/330893/WHO-nCoV-Clinical-2020.3- eng.pdf?sequence=1&isAllowed=y [Last accessed on 2020 Jan 25].
36. Johns Hopkins Center for Systems Science and Engineering (2020) Coronavirus COVID-19 Global Cases. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/ index.html#/bda7594740fd40299423467b48e9ecf6.20 [Last accessed on 17 Oct 20].
37. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
38. Pan Y, Guan H. Imaging changes in patients with 2019- nCov. Eur Radiol 2020;30:3612-3.
39. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology 2020;296:E15-25.
40. Ng MY, Lee EY, Yang J, Yang F, Li X, Wang H, et al. Imaging profile of the COVID-19 infection: Radiologic findings and literature review. Radiol Cardiothorac Imaging 2020;2:e200034.
41. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020;295:715-21.
42. Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, et al. 2019 Novel coronavirus (COVID-19) pneumonia: Serial computed tomography findings. Korean J Radiol 2020;21:501-4.
43. Wong HY, Lam HY, Fong AH, Leung ST, Chin TW, Lo CS, et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020;296:E72-8.
44. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the fleischner society. Radiology 2020;296:172-80.
45. Jacobi A, Chung M, Bernheim A, Eber C. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review. Clin Imaging 2020;64:35-42.
46. Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A. Coronavirus (COVID-19) outbreak: What the department of radiology should know. J Am Coll Radiol 2020;17:447-51.
47. Litmanovich DE, Chung M, Kirkbride RR, Kicska G, Kanne JP. Review of chest radiograph findings of COVID-19 pneumonia and suggested reporting language. J Thorac Imaging 2020;35:354-60.